| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 27-Nov-2009 | Zacks Investment Research Inc. |
N/A
| FACET BIOTECH (FACT) Zacks Company Snapshot | 1 |
$10 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: AVGN , CLDX , CRIS , FACT , LJPC , PPHM , VION -- DRUGS | 3 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: FACET BIOTECH -- FACT | 1 |
$4 |
| 25-Nov-2009 | Zacks Investment Research Inc. |
N/A
| FACET BIOTECH (FACT) Zacks Company Snapshot | 1 |
$10 |
| 24-Nov-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of FACET BIOTECH CORP-SPN including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
| 24-Nov-2009 | Zacks Investment Research Inc. |
N/A
| FACET BIOTECH (FACT) Zacks Company Snapshot | 1 |
$10 |
| 19-Nov-2009 | Zacks Investment Research Inc. |
N/A
| FACET BIOTECH (FACT) Zacks Company Snapshot | 1 |
$10 |
| 18-Nov-2009 | Zacks Investment Research Inc. |
N/A
| FACET BIOTECH (FACT) Zacks Company Snapshot | 1 |
$10 |
| 17-Nov-2009 | Zacks Investment Research Inc. |
N/A
| FACET BIOTECH (FACT) Zacks Company Snapshot | 1 |
$10 |
0.34% Nasdaq 
0.06 (0.36%) 
Research Reports
